News

Researchers from the Blanchette Rockefeller Neuroscience Institute (BRNI) have gathered evidence of the possible role of protein kinase C epsilon (PKCe) in the treatment of Alzheimer’s disease (AD). The news was recently announced by Neurotrope, a pharmaceutical company collaborating with BRNI in the development of bryostatin, a potent modulator of PKCe,…

Researchers at Brigham and Women’s Hospital (BWH) continue to make important contributions to the advancement of further understanding the underlying causes of Alzheimer’s disease. After last week’s announcement that BWH scientists have determined that decreased brain activity is linked to a decline in the ability to conduct daily tasks…

Independent research by the Home Instead Senior Care network of seniors, adult children, senior care and legal professionals provides new insights into the dynamics of the conversations that do and do not take place between Baby Boomers and their aging parents. A new survey finds approximately 80 million Americans…

Individuals with frontotemporal degeneration (FTD) may soon benefit from research priorities directed toward curing Alzheimer’s disease and other forms of dementia. The Association of Frontotemporal Degeneration (AFTD) broke word of plans to formally include FTD in national research priorities by the year 2025. According to AFTD Executive Director Susan…

Typical daily tasks may not seem like the type that require high brain function. However, activities within our daily routine, which include paying the bills, going to appointments, and even driving — all of which are known as “instrumental activities” — are directly linked to optimal performance in specific…

A new free access paper published online before print in the journal JAMA Neurology, entitled, “Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function” (JAMA Neurol. Published online August 11, 2014. DOI: 10.1001/.jamaneurol.2014.2011) documents a 40-year-old African American man referred…

The California Supreme Court recently decided, by a 5-2 decision, that people with Alzheimer’s disease cannot be held responsible for injuries caused to their in-home caregivers, and that a prior awareness of this fact precludes a legal accusation, CBS News recently reported, quoting an Associated Press report. According…

Vitamin D, known as the sunshine vitamin due to its mechanism of production in the body, is usually associated with calcium absorption and bone health, but researchers are finding that vitamin D is strongly linked to the risk for Alzheimer’s disease and dementia. Dr. David Llewellyn, from the University…

Increasing incidence of Alzheimer’s Disease and other forms of senile dementia as the population demographic ages has raised general anxiety levels. It’s not entirely paranoia. Risk of developing Alzheimer’s doubles every five years after age 65. Toronto, Canada-based Cogniciti, Inc. cites a recent Brain Health Study (about which more…

Researchers at Yale School of Medicine have discovered a new drug compound with the capacity to reverse the brain deficits of Alzheimer’s disease (AD) in an animal model. In this month’s issue of PLoS Biology, in an article entitled, “Inhibitor of the Tyrosine Phosphatase STEP Reverses Cognitive Deficits…